Laboratory results suggested that when infected with COVID-19, the PD patients experienced a heightened inflammatory response, including higher white blood cell count and neutrophil count, lower lymphocyte count, a higher neutrophil/lymphocyte ratio (N/L) and CRP levels (Table 3). This evidence concerns the gene CRP and Parkinson disease.